发明授权
US5976785A Competitive assays for determining the effectiveness of a human
immunodeficiency virus type 2 (HIV-2) antiviral agent, employing
peptides and proteins of HIV-2
失效
用于确定使用HIV-2的肽和蛋白质的人类免疫缺陷病毒2型（HIV-2）抗病毒剂的有效性的竞争性测定
- 专利标题： Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
- 专利标题（中）： 用于确定使用HIV-2的肽和蛋白质的人类免疫缺陷病毒2型（HIV-2）抗病毒剂的有效性的竞争性测定
-
申请号： US811150申请日： 1991-12-20
-
公开(公告)号： US5976785A公开(公告)日： 1999-11-02
- 发明人: Marc Alizon , Luc Montagnier , Denise Guetard , Francois Clavel , Pierre Sonigo , Mireille Guyader
- 申请人： Marc Alizon , Luc Montagnier , Denise Guetard , Francois Clavel , Pierre Sonigo , Mireille Guyader
- 申请人地址： FRX Paris
- 专利权人： Institut Pasteur
- 当前专利权人： Institut Pasteur
- 当前专利权人地址： FRX Paris
- 优先权： FRX8600911 19860122; FRX8601635 19860206; FRX8601985 19860213; FRX8603881 19860318; FRX8604215 19860324
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K39/00 ; A61P31/18 ; C07K7/06 ; C07K14/16 ; C12N7/00 ; C12Q1/70 ; G01N33/569
摘要：
A method for diagnosing an HIV-2 (LAV-II) infection and a kit containing reagents for the same is disclosed. These reagents include cDNA probes which are capable of hybridizing to at least a portion of the genome of HIV-2. In one embodiment, the DNA probes are capable of hybridizing to the entire genome of HIV-2. These reagents also include polypeptides encoded by some of these DNA sequences.
公开/授权文献
信息查询
IPC分类:
